title: Cardiac sympathetic nervous activity during myocardial ischemia, reperfusion and ventricular fibrillation in the dog--effects of intravenous lidocaine.
abstract: In 12 open-chest dogs, cardiac sympathetic nervous activity (CSNA) was recorded before and after occlusion of the left anterior descending coronary artery as well as during reperfusion and ventricular fibrillation (VF). In 7 control animals, CSNA did not significantly differ from preocclusion levels when determined 20 min after occlusion (+3.5 +/- 1.5%, mean +/- SEM) and up to 15 min following reperfusion (+1.5 +/- 0.6%). However, VF was associated with a potential increase in CSNA by 106 +/- 15.5% (p less than 0.001). The effect of lidocaine (6 mg/kg) on cardiac sympathetic tone was examined in 5 additional animals. Lidocaine reduced control CSNA by 23 +/- 4.7% (p less than 0.001); subsequent ischemia and reperfusion did not substantially change the level of preocclusion activity. CSNA decreased significantly also during VF (52 +/- 4.2%, p less than 0.001). In conclusion, efferent CSNA was slightly altered in the course of acute myocardial ischemia and reperfusion, but significantly increased during VF. Lidocaine produced marked attenuation of CSNA in anesthetized dogs.
authors.affiliation: Department of Cardiology, University of Heidelberg, FRG.
authors.forename: I
authors.initials: I
authors.lastname: Aidonidis
authors.forename: J
authors.initials: J
authors.lastname: Brachmann
authors.forename: H
authors.initials: H
authors.lastname: Seller
authors.forename: K
authors.initials: K
authors.lastname: Demowsky
authors.forename: J
authors.initials: J
authors.lastname: Czachurski
authors.forename: W
authors.initials: W
authors.lastname: Kübler
mesh_terms: D000818:Animals; D001794:Blood Pressure / Q000502:physiology; D003327:Coronary Disease / Q000503:physiopathology*; D004285:Dogs; D004562:Electrocardiography; D005260:Female; D006321:Heart / Q000294:innervation*; D006329:Heart Conduction System / Q000503:physiopathology; D008012:Lidocaine / Q000494:pharmacology*; D008297:Male; D015428:Myocardial Reperfusion Injury / Q000503:physiopathology*; D013564:Sympathetic Nervous System / Q000187:drug effects / Q000503:physiopathology*; D014693:Ventricular Fibrillation / Q000503:physiopathology*
chemical_list: D008012:Lidocaine